Phonological encoding of young children who stutter.
Kristin M Pelczarski, J Scott Yaruss
https://pubmed.ncbi.nlm.nih.gov/24759190/Actively Recruiting
Led by Kansas State University · Updated on 2026-08-05
10
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating whether repeated transcranial magnetic stimulation rTMS can treat stuttering in adults aged 18 to 65 years. This pilot study aims to understand if rTMS causes changes in the brain of people who stutter and whether these brain changes lead to reduced stuttering. The study focuses on modulating brain activity in speech and motor areas using a device-based intervention. Participants will receive 10 sessions of rTMS delivered to the left inferior frontal gyrus, a speech-related brain area, using a neuronavigation system guided by individual MRI scans. Before treatment, structural and resting-state functional MRIs will be taken to identify stimulation targets. The rTMS will be applied at 10 Hz frequency for 10 minutes per session at 120% of the resting motor threshold. The study includes three visits before treatment for baseline tests and two visits after treatment to assess changes. During the study, participants will undergo various assessments including resting-state electroencephalography rs-EEG for brain connectivity, eye tracking during phonological memory tasks, and spontaneous speech samples to measure stuttering severity. These measures will be taken at baseline, immediately after treatment, and one week post-treatment. Researchers will monitor changes in brain function and stuttering behavior throughout the study, which runs from February 2026 to December 2028.
CONDITIONS
Using Transcranial Magnetic Stimulation to Treat Stuttering
K
Kristin Pelczarski, Ph.D.
J
Julio Hernandez Pavon, Ph.D., DSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Kansas State University
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | TMS as studied in the trial | Current-care: Speech-language therapy |
|---|---|---|
| What it is | Transcranial Magnetic Stimulation is a noninvasive brain stimulation device applied to speech and motor regions to modulate cortical activity in adults who currently stutter. | Speech-language therapy is a behavioral treatment approach using structured speech exercises and strategies to improve speech fluency and reduce stuttering in adults. |
| Primary use | Studied as a noninvasive intervention intended to increase left-hemisphere cortical activation during speech and improve functional connectivity in adults who stutter. | Used to target speech fluency improvement, reduce stuttering severity, and support communication skills through behavioral and cognitive strategies. |
| How it is given or performed | TMS is administered using a device coil positioned over specific speech and motor areas. Sessions involve magnetic pulses to modulate neuronal activity. | Speech-language therapy is delivered by trained therapists using personalized speech exercises, fluency techniques, and cognitive counseling, typically in weekly sessions. |
| Evidence status | TMS for stuttering in adults is under clinical investigation. Published evidence remains limited and longer-term outcomes are not yet established. | Speech-language therapy has extensive published evidence showing short-term and long-term speech fluency improvement in adults who stutter. |
| Important limitations | TMS remains investigational for stuttering, trial results are not yet available, and safety profile is not fully established in this population. | Speech-language therapy may not eliminate stuttering entirely and effectiveness varies between individuals. Some adults experience only partial improvement or require ongoing support. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Before treatment begins
Participants visit the lab 3 times to complete MRI scans, EEG recordings, eye tracking, and speech assessments to establish baseline measurements.
3 visits
Duration - 10 days
Participants receive 10 sessions of transcranial magnetic stimulation applied to the left inferior frontal gyrus over 10 days.
10 treatment sessions
Duration - One week after treatment
Participants return to the lab 2 times to repeat EEG, eye tracking, and speech tests to measure changes after treatment.
2 visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Kristin M Pelczarski, J Scott Yaruss
https://pubmed.ncbi.nlm.nih.gov/24759190/Nicole E Neef, Alfred Anwander, Christoph Bütfering...
https://pubmed.ncbi.nlm.nih.gov/29228195/Kristin M Pelczarski, J Scott Yaruss
https://pubmed.ncbi.nlm.nih.gov/27280891/Julio C Hernandez-Pavon, Richard L Harvey
https://pubmed.ncbi.nlm.nih.gov/30954150/Tyler K Perrachione, Satrajit S Ghosh, Irina Ostrovskaya...
https://pubmed.ncbi.nlm.nih.gov/28631005/Courtney T Byrd, Megann McGill, Evan Usler
https://pubmed.ncbi.nlm.nih.gov/25680736/Julio C Hernandez-Pavon, Domenica Veniero, Til Ole Bergmann...
https://pubmed.ncbi.nlm.nih.gov/36828303/Kristin M Pelczarski, Anna Tendera, Matthew Dye...
https://pubmed.ncbi.nlm.nih.gov/29976115/Julie D Anderson, Stacy A Wagovich, Nancy E Hall
https://pubmed.ncbi.nlm.nih.gov/16814376/Nicole E Neef, T N Linh Hoang, Andreas Neef...
https://pubmed.ncbi.nlm.nih.gov/25595146/Kansas State University
Lead Sponsor